Comparison of Epidemiological Characteristics Between ESBL and Non-ESBL Isolates of Clinically Isolated Escherichia coli from 2014 to 2022: A Single-Center Study.
Infection and drug resistance(2023)
Abstract
Carbapenems remain the optimal choice for treating extended spectrum beta-lactamase-producing infections (sensitivity rate: 98%). Colistin (87.7%) and amikacin (87%) exhibited good antibacterial activities against carbapenem-resistant . Long-term and continuous epidemiological surveillance of can facilitate the development of preventive strategies and control policies.
MoreTranslated text
Key words
escherichia coli,epidemiological characteristics,non-esbl,single-center
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined